IMAB (I-Mab) Wutah bathi resik saben saham ing taun iki

IMAB (I-Mab) - tandha merek perusahaan

The geopolitical confrontation between the US and China limits the current international research of I-Mab (IMAB), although the long-term scale of antibody development is sustained by global outsourcing. A comparison of annual EPS growth visualizes this conflict of interest, where -179.90 expresses the latest level of the metric. The final balance is complicated by a risky business split and dependence on external financing, creating pressure on capital.

Wutah bathi saben saham ing taun lumaku: I-Mab Biopharma Co., Ltd. (IMAB) kanggo 04.07.2022 - 30.10.2025
Produk mawa merek I-Mab Biopharma

For I-Mab (IMAB), whose success depends on antibody clinical trials rather than market cycles, the current EPS YoY growth rate on the GURU.Markets platform serves as an indicator of development financial efficiency. This metric captures the percentage change in net profit per share relative to the previous year, allowing investors to assess capitalization dynamics and business model sustainability regardless of the macroeconomic backdrop.

Pesaing wigati

Wutah bathi saben saham ing taun iki INCY|HCM (HUTCHMED Ltd) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Nuvation Corp (NUVB)|Wutah bathi saben saham ing taun lumaku Day One (DAWN)|MNPR - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Inhibrx Biosciences, Inc. INBX|Fennec Pharma - Wutah bathi saben saham ing taun lumaku|HRTX - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Nuvectis Pharma, Inc|CHRS: Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku corbuspharma.com CRBP|Wutah bathi resik saben saham ing taun iki CRDF|Kacepetan wutah bathi saben saham ing taun lumaku BeyondSpring, Inc. BYSI|Wutah bathi resik saben saham ing taun iki BCAB (BioAtla, Inc.)|LIXT (Lixte Biotechnology, Inc.) - Tambahing bathi saben saham ing taun lumaku|Citius Pharmaceuticals, Inc. - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku CLRB (cellectar.com)|BioLineRx - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku CANF (Can-Fite BioPharma Ltd)|APRE: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Kazia Therapeutics Limited (KZIA)|Wutah bathi saben saham ing taun lumaku Silexion Therapeutics Corp.|NCNA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku CMRX|Wutah bathi ing taun lumaku Cyclacel Pharmaceuticals, Inc. (CYCC)|Wutah bathi saben saham ing taun lumaku G1 Therapeutics GTHX|KRON (Kronos Bio Corporation) - Dinamika bathi saben saham ing taun lumaku|KTRA: Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku oncternal.com|PRTG: Wutah bathi ing taun lumaku